Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Decision analysis: a practical example

T J Smith1, B E Hillner

  • 1Department of Internal Medicine, Massey Cancer Center, Medical College of Virginia/Virginia Commonwealth University Richmond, USA.

Oncology (Williston Park, N.Y.)
|November 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacoeconomic issues in bisphosphonate treatment of metastatic bone disease.

Seminars in oncology·2001
Same author

Is cancer care best at high-volume providers?

Current oncology reports·2001
Same author

Ensuring quality cancer care by the use of clinical practice guidelines and critical pathways.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2001
Same author

Burden of illness associated with metastatic melanoma: an audit of 100 consecutive referral center cases.

Cancer·2001
Same author

Cost-effectiveness analysis of exemestane compared with megestrol in patients with advanced breast carcinoma.

Cancer·2001
Same author

Role of perspective and other uncertainties in cost-effectiveness assessments in advanced prostate cancer.

Journal of the National Cancer Institute·2000
Same journal

Emerging T-Cell Engagers and Novel Immunotargets in Multiple Myeloma.

Oncology (Williston Park, N.Y.)·2026
Same journal

Access to Care and the Affordable Care Act: Why Do Problems Exist 15 Years Later?

Oncology (Williston Park, N.Y.)·2026
Same journal

Synchronous Endometrial and Ovarian Cancers: A Case Study and Literature Review.

Oncology (Williston Park, N.Y.)·2026
Same journal

Perceived Social Support, Anxiety, and Depression Among Women With Breast Cancer.

Oncology (Williston Park, N.Y.)·2026
Same journal

Before Certainty.

Oncology (Williston Park, N.Y.)·2026
Same journal

Adult T-Cell Leukemia/Lymphoma and Epstein-Barr Virus-Positive DLBCL: A Rare Concomitant Association.

Oncology (Williston Park, N.Y.)·2026
See all related articles

Decision analysis offers a framework for comparing cancer treatment effectiveness, patient preferences, and costs. This approach aids providers and health economists in resource allocation, optimizing outcomes like life-years gained for healthcare spending.

Area of Science:

  • Health Economics
  • Decision Science
  • Oncology

Background:

  • Cancer treatments face challenges regarding toxicity, efficacy, and cost.
  • Decision analysis provides a structured method for evaluating medical interventions.

Purpose of the Study:

  • To demonstrate the application of decision analysis in assessing cancer treatment value.
  • To evaluate the cost-effectiveness of high-dose chemotherapy for high-risk stage II breast cancer.

Main Methods:

  • Utilizing decision analysis to compare alternative treatment strategies.
  • Incorporating patient preferences and healthcare costs into the analysis.
  • Calculating cost-effectiveness using metrics like dollars per life-year gained.

Main Results:

Related Experiment Videos

  • Decision analysis quantifies treatment benefits and allows for explicit comparisons.
  • Identifies optimal resource allocation based on maximizing life-years gained per dollar spent.
  • Provides a framework for "what if" scenarios and simulations in clinical trials.

Conclusions:

  • Decision analysis is a valuable tool for providers, health economists, and clinical trialists.
  • Facilitates rational resource allocation in cancer care.
  • Demonstrates the societal value of specific cancer treatments, such as high-dose chemotherapy.